ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 46

$576K Total Retail Price of All Prescriptions

Rank: 6 out of 46

211 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 211 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

32% of this provider’s 211 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 5,959 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 289 130 S3 1 1
CYMBALTA 241 190 2 32
LEVOTHYROXINE SODIUM 198 194 3 4
RANITIDINE HCL 171 153 4 26
POLYETHYLENE GLYCOL 3350 143 138 5 34
LISINOPRIL 142 110 6 3
FUROSEMIDE 129 121 7 7
PRAVASTATIN SODIUM 126 108 8 12
OMEPRAZOLE 125 98 9 5
SUBOXONE 122 0 10 92
NAMENDA 117 114 11 24
ATORVASTATIN CALCIUM 112 99 12 20
TRAZODONE HCL 109 57 13 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 76 14 27
AMLODIPINE BESYLATE 106 102 14 8
CARVEDILOL 104 95 16 29
CITALOPRAM HBR 103 94 17 23
PRENATAL PLUS 101 101 18 167
WARFARIN SODIUM 93 89 19 13
DONEPEZIL HCL 92 92 20 19
GABAPENTIN 91 62 21 11
MIRTAZAPINE 87 72 22 66
TAMSULOSIN HCL 82 52 23 25
POTASSIUM CHLORIDE 81 81 24 15
METFORMIN HCL 78 61 25 9
TRAMADOL HCL 75 60 26 16
SIMVASTATIN 73 61 27 6
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 66 28 95
LOVAZA 70 70 29 143
FENTANYL 70 22 S2 29 33
LANTUS 68 68 31 35
SPIRIVA 64 53 32 68
VENLAFAXINE HCL ER 63 28 33 152
OLANZAPINE 56 56 34 83
OXYCODONE HCL 55 0 S2 35 63
SPIRONOLACTONE 51 46 36 67
ISOSORBIDE MONONITRATE ER 51 50 36 47
QUETIAPINE FUMARATE 51 34 36 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.